Productivity outcomes following endoscopic sinus surgery for recurrent acute rhinosinusitis

Toby O. Steele; Kara Y. Detwiller; Jess C. MacE; E. Bradley Strong; Timothy L. Smith; Jeremiah A. Alt

doi:10.1002/lary.25705

Productivity outcomes following endoscopic sinus surgery for recurrent acute rhinosinusitis

Toby O. Steele, Kara Y. Detwiller, Jess C. MacE, E. Bradley Strong, Timothy L. Smith, Jeremiah A. Alt

Otolaryngology

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Objectives/Hypothesis We sought to evaluate preoperative and postoperative productivity losses and quality of life (QOL) impairment reported by patients with recurrent acute rhinosinusitis (RARS) as compared to patients with chronic rhinosinusitis without nasal polyposis (CRSsNP). Study Design Prospective, multi-institutional, nested case-control. Methods Participants with RARS (n = 20) and CRSsNP (n = 20) undergoing endoscopic sinus surgery (ESS) were enrolled as part of a prospective cohort study. For comparison, participants diagnosed with RARS cases were age/gender-matched to control participants diagnosed with CRSsNP using a 1:1 ratio. Results RARS and CRSsNP participants were followed for ∼14 months postoperatively. Productivity losses were reported as the number of days missed from normal productive activities out of the previous 90 days. RARS participants reported similar baseline productivity losses (12.6 ± 27.1 [standard deviation]) as participants with CRSsNP (11.7 ± 20.9; P =.314). Postoperatively, improvement in productivity losses was similar between RARS participants and CRSsNP controls (-6.7 ± 20.0 vs. -9.8 ± 19.1; P =.253). Preoperative and postoperative disease-specific QOL measures (Sino-Nasal Outcomes Test-22 and Rhinosinusitis Disability Index) were similar between the two groups. RARS participants reported a significant decrease in days of previous antibiotic (P =.009) and nasal decongestant (P =.004) use following ESS, whereas participants with CRSsNP reported a significant decrease in antibiotic (P =.002) and oral corticosteroid use (P =.002). Conclusions RARS patients report baseline productivity losses and disease-specific QOL impairment to levels that parallel those with CRSsNP. Patients with RARS report improvement in QOL following ESS in all disease-specific QOL measures and in several medication measures. Productivity losses and postoperative improvements are similar between patients with RARS and CRSsNP.

Original language	English (US)
Pages (from-to)	1046-1053
Number of pages	8
Journal	Laryngoscope
Volume	126
Issue number	5
DOIs	https://doi.org/10.1002/lary.25705
State	Published - May 1 2016

Keywords

Sinusitis
case-control studies
medical therapy management
outcome assessment
patient outcome assessment

ASJC Scopus subject areas

Otorhinolaryngology

Access to Document

10.1002/lary.25705

Cite this

@article{d4eed6fd70c54e3b8a7dec0129af3078,

title = "Productivity outcomes following endoscopic sinus surgery for recurrent acute rhinosinusitis",

abstract = "Objectives/Hypothesis We sought to evaluate preoperative and postoperative productivity losses and quality of life (QOL) impairment reported by patients with recurrent acute rhinosinusitis (RARS) as compared to patients with chronic rhinosinusitis without nasal polyposis (CRSsNP). Study Design Prospective, multi-institutional, nested case-control. Methods Participants with RARS (n = 20) and CRSsNP (n = 20) undergoing endoscopic sinus surgery (ESS) were enrolled as part of a prospective cohort study. For comparison, participants diagnosed with RARS cases were age/gender-matched to control participants diagnosed with CRSsNP using a 1:1 ratio. Results RARS and CRSsNP participants were followed for ∼14 months postoperatively. Productivity losses were reported as the number of days missed from normal productive activities out of the previous 90 days. RARS participants reported similar baseline productivity losses (12.6 ± 27.1 [standard deviation]) as participants with CRSsNP (11.7 ± 20.9; P =.314). Postoperatively, improvement in productivity losses was similar between RARS participants and CRSsNP controls (-6.7 ± 20.0 vs. -9.8 ± 19.1; P =.253). Preoperative and postoperative disease-specific QOL measures (Sino-Nasal Outcomes Test-22 and Rhinosinusitis Disability Index) were similar between the two groups. RARS participants reported a significant decrease in days of previous antibiotic (P =.009) and nasal decongestant (P =.004) use following ESS, whereas participants with CRSsNP reported a significant decrease in antibiotic (P =.002) and oral corticosteroid use (P =.002). Conclusions RARS patients report baseline productivity losses and disease-specific QOL impairment to levels that parallel those with CRSsNP. Patients with RARS report improvement in QOL following ESS in all disease-specific QOL measures and in several medication measures. Productivity losses and postoperative improvements are similar between patients with RARS and CRSsNP.",

keywords = "Sinusitis, case-control studies, medical therapy management, outcome assessment, patient outcome assessment",

author = "Steele, {Toby O.} and Detwiller, {Kara Y.} and MacE, {Jess C.} and Strong, {E. Bradley} and Smith, {Timothy L.} and Alt, {Jeremiah A.}",

note = "Publisher Copyright: {\textcopyright} 2015 The American Laryngological, Rhinological and Otological Society, Inc.",

year = "2016",

month = may,

day = "1",

doi = "10.1002/lary.25705",

language = "English (US)",

volume = "126",

pages = "1046--1053",

journal = "Laryngoscope",

issn = "0023-852X",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Productivity outcomes following endoscopic sinus surgery for recurrent acute rhinosinusitis

AU - Steele, Toby O.

AU - Detwiller, Kara Y.

AU - MacE, Jess C.

AU - Strong, E. Bradley

AU - Smith, Timothy L.

AU - Alt, Jeremiah A.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Objectives/Hypothesis We sought to evaluate preoperative and postoperative productivity losses and quality of life (QOL) impairment reported by patients with recurrent acute rhinosinusitis (RARS) as compared to patients with chronic rhinosinusitis without nasal polyposis (CRSsNP). Study Design Prospective, multi-institutional, nested case-control. Methods Participants with RARS (n = 20) and CRSsNP (n = 20) undergoing endoscopic sinus surgery (ESS) were enrolled as part of a prospective cohort study. For comparison, participants diagnosed with RARS cases were age/gender-matched to control participants diagnosed with CRSsNP using a 1:1 ratio. Results RARS and CRSsNP participants were followed for ∼14 months postoperatively. Productivity losses were reported as the number of days missed from normal productive activities out of the previous 90 days. RARS participants reported similar baseline productivity losses (12.6 ± 27.1 [standard deviation]) as participants with CRSsNP (11.7 ± 20.9; P =.314). Postoperatively, improvement in productivity losses was similar between RARS participants and CRSsNP controls (-6.7 ± 20.0 vs. -9.8 ± 19.1; P =.253). Preoperative and postoperative disease-specific QOL measures (Sino-Nasal Outcomes Test-22 and Rhinosinusitis Disability Index) were similar between the two groups. RARS participants reported a significant decrease in days of previous antibiotic (P =.009) and nasal decongestant (P =.004) use following ESS, whereas participants with CRSsNP reported a significant decrease in antibiotic (P =.002) and oral corticosteroid use (P =.002). Conclusions RARS patients report baseline productivity losses and disease-specific QOL impairment to levels that parallel those with CRSsNP. Patients with RARS report improvement in QOL following ESS in all disease-specific QOL measures and in several medication measures. Productivity losses and postoperative improvements are similar between patients with RARS and CRSsNP.

AB - Objectives/Hypothesis We sought to evaluate preoperative and postoperative productivity losses and quality of life (QOL) impairment reported by patients with recurrent acute rhinosinusitis (RARS) as compared to patients with chronic rhinosinusitis without nasal polyposis (CRSsNP). Study Design Prospective, multi-institutional, nested case-control. Methods Participants with RARS (n = 20) and CRSsNP (n = 20) undergoing endoscopic sinus surgery (ESS) were enrolled as part of a prospective cohort study. For comparison, participants diagnosed with RARS cases were age/gender-matched to control participants diagnosed with CRSsNP using a 1:1 ratio. Results RARS and CRSsNP participants were followed for ∼14 months postoperatively. Productivity losses were reported as the number of days missed from normal productive activities out of the previous 90 days. RARS participants reported similar baseline productivity losses (12.6 ± 27.1 [standard deviation]) as participants with CRSsNP (11.7 ± 20.9; P =.314). Postoperatively, improvement in productivity losses was similar between RARS participants and CRSsNP controls (-6.7 ± 20.0 vs. -9.8 ± 19.1; P =.253). Preoperative and postoperative disease-specific QOL measures (Sino-Nasal Outcomes Test-22 and Rhinosinusitis Disability Index) were similar between the two groups. RARS participants reported a significant decrease in days of previous antibiotic (P =.009) and nasal decongestant (P =.004) use following ESS, whereas participants with CRSsNP reported a significant decrease in antibiotic (P =.002) and oral corticosteroid use (P =.002). Conclusions RARS patients report baseline productivity losses and disease-specific QOL impairment to levels that parallel those with CRSsNP. Patients with RARS report improvement in QOL following ESS in all disease-specific QOL measures and in several medication measures. Productivity losses and postoperative improvements are similar between patients with RARS and CRSsNP.

KW - Sinusitis

KW - case-control studies

KW - medical therapy management

KW - outcome assessment

KW - patient outcome assessment

UR - http://www.scopus.com/inward/record.url?scp=84973520081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973520081&partnerID=8YFLogxK

U2 - 10.1002/lary.25705

DO - 10.1002/lary.25705

M3 - Article

C2 - 26749066

AN - SCOPUS:84973520081

SN - 0023-852X

VL - 126

SP - 1046

EP - 1053

JO - Laryngoscope

JF - Laryngoscope

IS - 5

ER -

Productivity outcomes following endoscopic sinus surgery for recurrent acute rhinosinusitis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this